MFG Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.64M Buy
3,143
+130
+4% +$153K 2.64% 6
2026
Q2
$3.61M Buy
3,013
+935
+45% +$955K 2.59% 7
2026
Q1
$1.91M Sell
2,078
-733
-26% -$743K 1.58% 28
2025
Q4
$3.02M Sell
2,811
-209
-7% -$200K 2.35% 11
2025
Q3
$2.3M Buy
3,020
+923
+44% +$687K 1.74% 25
2025
Q2
$1.63M Sell
2,097
-627
-23% -$487K 1.38% 41
2025
Q1
$2.25M Sell
2,724
-15
-0.5% -$12.5K 2.15% 17
2024
Q4
$2.11M Buy
+2,739
New +$2.27M 1.94% 25

Other funds holding LLY

MFG Wealth Management's LLY Position: Q3 2026 in Review

MFG Wealth Management increased its Eli Lilly (LLY) stake by 4.3% in Q3 2026, buying an estimated $153K and bringing the position to 3,143 shares worth $3.64M. The position accounts for 2.64% of the portfolio, ranked #6.

MFG Wealth Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • MFG Wealth Management held 3,143 shares of Eli Lilly worth $3.64M as of Q3 2026.
  • MFG Wealth Management bought 130 Eli Lilly shares in Q3 2026, an estimated $153K.
  • Eli Lilly made up 2.64% of MFG Wealth Management's portfolio in Q3 2026, its #6 holding.
  • MFG Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on MFG Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.